AstraZeneca added to its Imfinzi armamentarium on Monday after the immuno-oncology drug led to improved survival in liver ...

AstraZeneca and Andrews introduce SCREEN, a limited-edition t-shirt designed to spark conversation and inspire action on the benefits of early detection. Erin Andrews wearing limited-edition SCREEN ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic ...

Joshua Jackson is joined by Gritty to take the body check off the ice. AstraZeneca and Joshua Jackson have teamed up as part of a national public health campaign designed to encourage fans to Get Body ...

AstraZeneca has shared data it believes can rescue anselamimab from a phase 3 failure, linking the drug candidate to a 62% improvement in survival among a prespecified subgroup of ...

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit. Suarez will lead the execution of the ...

AstraZeneca's Oncology and Rare Disease segments delivered 16% and 15% growth, powered by IMFINZI and ULTOMIRIS, respectively ...

US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date AstraZeneca has proudly awarded $3.4 million to nonprofit ...

The FDA granted priority review for Datroway based on results from the TROPION-Breast02 Phase III trial.

May 2026Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor ...